How much profit has Ceapro made this year?
Ceapro has made 0 CAD this year.
Ceapro Net Income 2024
Ceapro Net Income
0 CAD
Ticker
CZO.V
ISIN
CA1499071076
WKN
931278
In 2024, Ceapro's profit amounted to 0 CAD, a 0% increase from the -4.71 M CAD profit recorded in the previous year.
The Ceapro Net Income history
| YEAR | NET INCOME (undefined CAD) |
|---|---|
| 2024e | - |
| 2023 | -4.71 |
| 2022 | 4.4 |
| 2021 | 3.37 |
| 2020 | 1.86 |
| 2019 | -1.13 |
| 2018 | -0.32 |
| 2017 | -0.96 |
| 2016 | 3.62 |
| 2015 | 4.92 |
| 2014 | 1.59 |
| 2013 | 0.18 |
| 2012 | -0.54 |
| 2011 | 0.58 |
| 2010 | 0.5 |
| 2009 | -0.07 |
| 2008 | -3.6 |
| 2007 | -1.39 |
| 2006 | -0.27 |
| 2005 | -0.06 |
| 2004 | -0.4 |
Ceapro Revenue, EBIT, Net Income CA1499071076 · 931278
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Ceapro, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Ceapro from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Ceapro’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Ceapro. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Ceapro’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Ceapro’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Ceapro’s growth potential.
Ceapro Revenue, EBIT and net profit per share
| Date | Ceapro Revenue | Ceapro EBIT | Ceapro Net Income |
|---|---|---|---|
| 2024e | 24.99 M undefined | 0 undefined | 0 undefined |
| 2023 | 9.63 M undefined | -6.31 M undefined | -4.71 M undefined |
| 2022 | 18.84 M undefined | 5.44 M undefined | 4.4 M undefined |
| 2021 | 17.2 M undefined | 3.25 M undefined | 3.37 M undefined |
| 2020 | 15.12 M undefined | 2.29 M undefined | 1.86 M undefined |
| 2019 | 12.88 M undefined | -380,960 undefined | -1.13 M undefined |
| 2018 | 11.59 M undefined | 191,810 undefined | -315,540 undefined |
| 2017 | 12.93 M undefined | 2.74 M undefined | -958,280 undefined |
| 2016 | 13.67 M undefined | 6.19 M undefined | 3.62 M undefined |
| 2015 | 10.67 M undefined | 3.83 M undefined | 4.92 M undefined |
| 2014 | 8.89 M undefined | 2.06 M undefined | 1.59 M undefined |
| 2013 | 6.52 M undefined | 510,000 undefined | 180,000 undefined |
| 2012 | 5.17 M undefined | -420,000 undefined | -540,000 undefined |
| 2011 | 5.79 M undefined | 760,000 undefined | 580,000 undefined |
| 2010 | 5.58 M undefined | 370,000 undefined | 500,000 undefined |
| 2009 | 4.37 M undefined | -360,000 undefined | -70,000 undefined |
| 2008 | 4.23 M undefined | -2.12 M undefined | -3.6 M undefined |
| 2007 | 3.45 M undefined | -1.26 M undefined | -1.39 M undefined |
| 2006 | 3.31 M undefined | -290,000 undefined | -270,000 undefined |
| 2005 | 2.68 M undefined | -250,000 undefined | -60,000 undefined |
| 2004 | 1.96 M undefined | -240,000 undefined | -400,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 1.96 M CAD | -240,000 CAD | -400,000 CAD |
| 2005 | 2.68 M CAD | -250,000 CAD | -60,000 CAD |
| 2006 | 3.31 M CAD | -290,000 CAD | -270,000 CAD |
| 2007 | 3.45 M CAD | -1.26 M CAD | -1.39 M CAD |
| 2008 | 4.23 M CAD | -2.12 M CAD | -3.6 M CAD |
| 2009 | 4.37 M CAD | -360,000 CAD | -70,000 CAD |
| 2010 | 5.58 M CAD | 370,000 CAD | 500,000 CAD |
| 2011 | 5.79 M CAD | 760,000 CAD | 580,000 CAD |
| 2012 | 5.17 M CAD | -420,000 CAD | -540,000 CAD |
| 2013 | 6.52 M CAD | 510,000 CAD | 180,000 CAD |
| 2014 | 8.89 M CAD | 2.06 M CAD | 1.59 M CAD |
| 2015 | 10.67 M CAD | 3.83 M CAD | 4.92 M CAD |
| 2016 | 13.67 M CAD | 6.19 M CAD | 3.62 M CAD |
| 2017 | 12.93 M CAD | 2.74 M CAD | -958,280 CAD |
| 2018 | 11.59 M CAD | 191,810 CAD | -315,540 CAD |
| 2019 | 12.88 M CAD | -380,960 CAD | -1.13 M CAD |
| 2020 | 15.12 M CAD | 2.29 M CAD | 1.86 M CAD |
| 2021 | 17.2 M CAD | 3.25 M CAD | 3.37 M CAD |
| 2022 | 18.84 M CAD | 5.44 M CAD | 4.4 M CAD |
| 2023 | 9.63 M CAD | -6.31 M CAD | -4.71 M CAD |
| 2024e | 24.99 M CAD | 0 CAD | 0 CAD |
Ceapro stock margins CA1499071076 · 931278
The Ceapro margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ceapro. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ceapro.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Ceapro's sales revenue. A higher gross margin percentage indicates that the Ceapro retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Ceapro's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Ceapro's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Ceapro's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Ceapro. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Ceapro's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Ceapro Margin History
| Ceapro Gross margin | Ceapro Profit margin | Ceapro EBIT margin | Ceapro Profit margin |
|---|---|---|---|
| 2024e | 41.07 % | 0 % | 0 % |
| 2023 | 41.07 % | -65.51 % | -48.89 % |
| 2022 | 58.48 % | 28.9 % | 23.34 % |
| 2021 | 60.87 % | 18.89 % | 19.57 % |
| 2020 | 50.41 % | 15.15 % | 12.27 % |
| 2019 | 42.28 % | -2.96 % | -8.79 % |
| 2018 | 52.95 % | 1.65 % | -2.72 % |
| 2017 | 56.26 % | 21.18 % | -7.41 % |
| 2016 | 68.4 % | 45.28 % | 26.47 % |
| 2015 | 65.89 % | 35.87 % | 46.14 % |
| 2014 | 53.58 % | 23.21 % | 17.93 % |
| 2013 | 47.55 % | 7.82 % | 2.76 % |
| 2012 | 47.39 % | -8.12 % | -10.44 % |
| 2011 | 56.13 % | 13.13 % | 10.02 % |
| 2010 | 45.52 % | 6.63 % | 8.96 % |
| 2009 | 48.51 % | -8.24 % | -1.6 % |
| 2008 | 37.59 % | -50.12 % | -85.11 % |
| 2007 | 47.83 % | -36.52 % | -40.29 % |
| 2006 | 57.4 % | -8.76 % | -8.16 % |
| 2005 | 61.19 % | -9.33 % | -2.24 % |
| 2004 | 71.43 % | -12.24 % | -20.41 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 71.43 % | -12.24 % | -20.41 % |
| 2005 | 61.19 % | -9.33 % | -2.24 % |
| 2006 | 57.4 % | -8.76 % | -8.16 % |
| 2007 | 47.83 % | -36.52 % | -40.29 % |
| 2008 | 37.59 % | -50.12 % | -85.11 % |
| 2009 | 48.51 % | -8.24 % | -1.6 % |
| 2010 | 45.52 % | 6.63 % | 8.96 % |
| 2011 | 56.13 % | 13.13 % | 10.02 % |
| 2012 | 47.39 % | -8.12 % | -10.44 % |
| 2013 | 47.55 % | 7.82 % | 2.76 % |
| 2014 | 53.58 % | 23.21 % | 17.93 % |
| 2015 | 65.89 % | 35.87 % | 46.14 % |
| 2016 | 68.4 % | 45.28 % | 26.47 % |
| 2017 | 56.26 % | 21.18 % | -7.41 % |
| 2018 | 52.95 % | 1.65 % | -2.72 % |
| 2019 | 42.28 % | -2.96 % | -8.79 % |
| 2020 | 50.41 % | 15.15 % | 12.27 % |
| 2021 | 60.87 % | 18.89 % | 19.57 % |
| 2022 | 58.48 % | 28.9 % | 23.34 % |
| 2023 | 41.07 % | -65.51 % | -48.89 % |
| 2024e | 41.07 % | 0 % | 0 % |
Ceapro Aktienanalyse
What does Ceapro do?
Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Ceapro's Profit Margins
The profit margins of Ceapro represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Ceapro's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Ceapro's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Ceapro's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Ceapro’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Ceapro stock
How has the profit developed compared to last year?
The profit has increased by 0% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Ceapro publish its earnings?
Ceapro publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Ceapro?
The profits of Ceapro are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Ceapro?
You can learn more about the earnings of Ceapro by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Ceapro pay?
Over the past 12 months, Ceapro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ceapro is expected to pay a dividend of 0 CAD.
What is the dividend yield of Ceapro?
The current dividend yield of Ceapro is .
When does Ceapro pay dividends?
Ceapro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ceapro?
Ceapro paid dividends every year for the past 0 years.
What is the dividend of Ceapro?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ceapro located?
Ceapro is assigned to the 'Commodities' sector.
Wann musste ich die Aktien von Ceapro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ceapro from 7/15/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/15/2024.
When did Ceapro pay the last dividend?
The last dividend was paid out on 7/15/2024.
What was the dividend of Ceapro in the year 2023?
In the year 2023, Ceapro distributed 0 CAD as dividends.
In which currency does Ceapro pay out the dividend?
The dividends of Ceapro are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ceapro
Our stock analysis for Ceapro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ceapro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
